EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study

Josée Savard iD, Catherine Filion, Claudia Mc Brearty, Aude Caplette-Gingras, Jocelyne Chiquette, Michel Dorval iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.6889 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Josée Savard und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, Université Laval, Québec, Québec, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors, Neoplasm Recurrence, Local, Fear. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CHU de Québec-Université Laval Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is preliminary evidence suggesting that FCR is a major problem for breast cancer survivors carrying a BRCA1/2 mutation. The goal of this qualitative study, conducted among women who were treated for breast cancer, was to provide a deeper understanding of how FCR is experienced in the context of a genetic predisposition to breast cancer.

Method

Three focus groups (90–110 min) were conducted with 19 breast cancer survivors carrying a BRCA1/2 mutation. The semistructured interview probed FCR level and impact, the role FCR played in the decision to have a prophylactic bilateral mastectomy and/or salpingo‐oophorectomy, the effect that surgery had on FCR, and the relevance of offering a psychological intervention targeting FCR to this population.

Results

Findings indicated that FCR was a significant issue in these women, even though a majority had undergone a prophylactic surgery. Patients strongly affirmed the need to develop and provide access to FCR interventions that are specifically adapted to the needs of this group.

Discussion

These results suggest that, although being the most effective medical option to reduce the actual risk of local recurrence (or second breast cancer), prophylactic surgery only partially reduces FCR. A psychological intervention targeting specifically FCR would be an appropriate complement to preventive surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCancer SurvivorsNeoplasm Recurrence, LocalFearQualitative ResearchMutationHumansFemaleMiddle AgedAdultGenes, BRCA2BRCA1 ProteinGenetic Predisposition to DiseaseFocus GroupsAgedGenes, BRCA1BRCA2 ProteinMastectomy

Stichwörter der Autor:innen

BRCA1/2 genetic mutationbreast cancerfear of cancer recurrencepsychological interventionqualitative study

Substanzen

BRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Autor:innen und Institutionen

  • School of Psychology, Université Laval, Québec, Québec, Canada.
  • Centre de recherche du CHU de Québec-Université Laval, Québec, Québec, Canada.
  • Université Laval Cancer Research Center, Québec, Québec, Canada.
  • Centre des maladies du sein, CHU de Québec-Université Laval, Québec, Québec, Canada.
  • Faculty of Medicine, Université Laval, Québec, Québec, Canada.
  • Faculty of Pharmacy, Université Laval, Québec, Québec, Canada.

ORCID-Profile: Josée Savard, Michel Dorval

Förderung

  • CHU de Québec-Université Laval Foundation

Zitieren

APA

Savard, J., Filion, C., Brearty, C. M., Caplette-Gingras, A., Chiquette, J., & Dorval, M. (2024). Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study. Cancer Medicine. https://doi.org/10.1002/cam4.6889

Vancouver

Savard J, Filion C, Brearty CM, Caplette-Gingras A, Chiquette J, Dorval M. Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study. Cancer Medicine. 2024. doi:10.1002/cam4.6889

BibTeX
@article{Savard2024,
  author = {Savard, Josée and Filion, Catherine and Brearty, Claudia Mc and Caplette-Gingras, Aude and Chiquette, Jocelyne and Dorval, Michel},
  title = {Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.6889}
}
Kostenlos starten →